Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.11 USD | -3.39% | -5.69% | -48.73% |
Financials (USD)
Sales 2024 * | 41.67M | Sales 2025 * | 126M | Capitalization | 669M |
---|---|---|---|---|---|
Net income 2024 * | -395M | Net income 2025 * | -334M | EV / Sales 2024 * | 3.97 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 330M | EV / Sales 2025 * | 2.69 x |
P/E ratio 2024 * |
-1.71
x | P/E ratio 2025 * |
-2.15
x | Employees | 487 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.53% |
Latest transcript on Sage Therapeutics, Inc.
1 day | -3.39% | ||
1 week | -5.69% | ||
1 month | -16.34% | ||
3 months | -49.18% | ||
6 months | -45.51% | ||
Current year | -48.73% |
Managers | Title | Age | Since |
---|---|---|---|
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Kimi Iguchi
DFI | Director of Finance/CFO | 61 | 13-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeff Jonas
BRD | Director/Board Member | 71 | 13-08-13 |
Steven Paul
FOU | Founder | 73 | 10-04-15 |
Barry Greene
CEO | Chief Executive Officer | 60 | 20-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.13% | 14 M€ | -5.07% | ||
0.21% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 11.11 | -3.39% | 999,518 |
24-05-30 | 11.5 | +5.89% | 1,040,275 |
24-05-29 | 10.86 | -8.97% | 1,624,178 |
24-05-28 | 11.93 | +1.27% | 885,337 |
24-05-24 | 11.78 | +4.06% | 770,833 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.73% | 669M | |
+11.91% | 118B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.82% | 21.96B | |
-10.12% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B |
- Stock Market
- Equities
- SAGE Stock